Paradigms for Treating Breast Cancers Have Changed: The One-Size-Fits-All Is no Longer True

Remy Salmon (1)
(1) HĂ´pital des Peupliers, Paris, France, France

Abstract

NA

Full text article

Generated from XML file

References

Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288-300.

Gherghe M, Bordea C, Blidaru A. Sentinel lymph node biopsy (SLNB) vs. axillary lymph node dissection (ALND) in the current surgical treatment of early stage breast cancer. J Med Life. 2015;8(2):176-80.

Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303-10.

Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017;318(10):918-26.

Sanz J, Zhao M, Rodriguez N, Granado R, Foro P, et al. Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. Biomed Res Int. 2018;2018:8321871.

Tuaeva NO, Falzone L, Porozov YB, Nosyrev AE, Trukhan VM, et al. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements. Cells. 2019;8(10).

Authors

Remy Salmon
dr.rjsalmon@gmail.com (Primary Contact)
1.
Salmon R. Paradigms for Treating Breast Cancers Have Changed: The One-Size-Fits-All Is no Longer True. Arch Breast Cancer [Internet]. 2019 Nov. 30 [cited 2024 Apr. 13];:141-6. Available from: https://archbreastcancer.com/index.php/abc/article/view/263

Article Details